Please login to the form below

Not currently logged in
Email:
Password:

Tanzeum

This page shows the latest Tanzeum news and features for those working in and with pharma, biotech and healthcare.

Sanofi's lixisenatide is back under FDA review

Sanofi's lixisenatide is back under FDA review

Meanwhile, new GLP-1 agonists that require dosing just once a week - including Eli Lilly's Trulicity (dulaglutide), GlaxoSmithKline's Tanzeum (albiglutide) AstraZeneca's Bydureon (exenatide) and Novo Nordisk's semaglutide -

Latest news

  • Type 2 diabetes market set to hit $39bn by 2021 Type 2 diabetes market set to hit $39bn by 2021

    Notable examples include two recently approved once-weekly GLP-1 receptor agonists, Tanzeum and Trulicity, and an orally administered GLP-1 receptor agonist, OG-217SC, which is in phase II development,

  • Novo Nordisk's oral GLP-1 analogue looks set for phase III Novo Nordisk's oral GLP-1 analogue looks set for phase III

    If the injectable version is approved it will have to compete with a number of similar products on the market - notably AstraZeneca's Bydureon (exenatide), GlaxoSmithKline's Tanzeum/Eperzan (albiglutide) and

  • Novo Nordisk's Xultophy debuts in Switzerland Novo Nordisk's Xultophy debuts in Switzerland

    s Tanzeum (albiglutide), AstraZeneca's Bydureon (exenatide) and Eli Lilly's recently-launched Trulicity (dulaglutide) offering once-weekly rather than once-daily injections.

  • Lilly launches GLP-1 agonist Trulicity in US Lilly launches GLP-1 agonist Trulicity in US

    Once-weekly treatment will challenge GSK's Tanzeum, AZ's Bydureon and Novo's Victoza in diabetes.  . ... Lilly has launched Trulicity in the same price region as Victoza but above Tanzeum, which GSK is selling at a discount.

  • FDA approves Lilly’s GLP-1 diabetes drug Trulicity FDA approves Lilly’s GLP-1 diabetes drug Trulicity

    The once-weekly treatment is set to compete with Bydureon, Tanzeum and Victoza. ... Competition is heating up, however, and GlaxoSmithKline has won approval for once-weekly albiglutide in the US under the name Tanzeum and in the EU under the name Eperzan.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics